What is the risk of cross-sensitivity between aspirin (acetylsalicylic acid) and Toradol (ketorolac) in patients with a known allergy to aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cross-Sensitivity Between Aspirin and Toradol (Ketorolac)

Patients with aspirin allergy should avoid ketorolac (Toradol) due to significant cross-sensitivity risk, as both medications belong to different chemical classes of NSAIDs but share similar mechanisms of action through COX-1 inhibition. 1

Understanding the Cross-Sensitivity Mechanism

Cross-sensitivity between aspirin and ketorolac occurs primarily through their shared pharmacological mechanism:

  • Both drugs inhibit cyclooxygenase-1 (COX-1) enzyme, altering arachidonic acid metabolism 1, 2
  • This is not a true IgE-mediated allergy but rather a pharmacological effect 2
  • Chemical classification: Aspirin belongs to salicylates while ketorolac is an acetic acid derivative NSAID 1

Types of Hypersensitivity Reactions

  1. NSAID-Exacerbated Respiratory Disease (AERD):

    • Most common in patients with asthma and nasal polyps
    • Prevalence up to 21% in adults with asthma 1
    • Symptoms include bronchospasm and rhinitis
    • High cross-reactivity between aspirin and other NSAIDs including ketorolac 3
  2. NSAID-Exacerbated Cutaneous Disease:

    • Worsening of pre-existing urticaria or angioedema
    • Cross-reactivity with other COX-1 inhibitors including ketorolac 2
  3. Single NSAID-Induced Reactions:

    • Specific to one NSAID chemical class
    • Less common than cross-reactive patterns 1

Clinical Implications and Management

For patients with known aspirin allergy:

  • Avoid ketorolac: The FDA label explicitly states ketorolac "should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs" 4
  • Severe reactions possible: Anaphylactic-like and bronchospastic life-threatening reactions have been reported with ketorolac use in aspirin-sensitive patients 3
  • All administration routes affected: Even topical ketorolac has been reported to cause severe asthma exacerbations in aspirin-sensitive patients 5

Alternative Options

For patients requiring anti-inflammatory or analgesic therapy:

  1. Acetaminophen (Paracetamol):

    • Generally safe in low to moderate doses (<1000mg)
    • May cause reactions in a small percentage of highly sensitive patients 6, 7
  2. Selective COX-2 Inhibitors:

    • Well tolerated by almost all aspirin-sensitive patients 7
    • Examples include celecoxib
    • Safer alternative for patients with aspirin hypersensitivity
  3. Aspirin Desensitization:

    • Option for patients requiring aspirin for cardiovascular protection
    • Should only be performed by specialists in controlled settings 2
    • Requires continued daily therapy to maintain tolerance

Key Precautions

  • Always obtain a complete history of aspirin/NSAID reactions, asthma, rhinitis, and nasal polyps before administering ketorolac 3
  • The combination of asthma and nasal polyps should raise suspicion for potential aspirin/NSAID sensitivity 1
  • Cross-reactivity is highest with strong COX-1 inhibitors like ketorolac 7
  • Patients with aspirin-sensitive asthma are at particularly high risk for severe reactions to ketorolac 3, 5

The evidence clearly demonstrates that ketorolac should be avoided in patients with known aspirin allergy due to the significant risk of cross-sensitivity reactions that can be severe and potentially life-threatening.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Patients with New Onset Aphasia and Aspirin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ketorolac-precipitated asthma.

Southern medical journal, 1994

Research

Aspirin sensitivity and allergy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.